Home » Industry Insights » Top Biotech News (21 July 2026)

Top Biotech News (21 July 2026)

Investigational mRNA Flu Vaccine Broadens Antibody Defenses, Sustains Immune “Training Hub” Longer Than Standard Shot

Summary:

An investigational mRNA flu vaccine generated broader, longer-lasting immune protection than a standard flu shot, potentially redefining how next-generation influenza vaccines are evaluated.

Jasper merges with Kira, while Tavneos rival sent to Mirador

Summary:

Jasper Therapeutics is being reborn via a merger with Nasdaq-listed immune-mediated disease biotech Kira Pharmaceuticals

GSK axes key cough drug candidate after phase 3 data disappoint

Summary:

GSK has discontinued its blockbuster cough drug candidate after disappointing phase 3 results, highlighting the challenges of developing effective treatments for chronic cough.

Veradermics keeps ‘momentum going’ as baldness drug helps women with hair loss

Summary:

An investigational oral hair loss treatment showed promising results in women, raising hopes for the first pill specifically approved for female pattern hair loss.

Understanding Agentic AI in Clinical Development

Summary:

Agentic AI could transform clinical development by coordinating complex workflows, helping researchers make faster, smarter decisions while maintaining human oversight and regulatory confidence.

Subscribe
to the latest updates in the newsletter

Related Solutions

  • Disease Modeling
  • Oncology
  • Organoid
  • Cosmetics
  • OECD TG
  • Zebrafish
  • Bioinfomatics
  • Live&3D Imaging
  • Molecular biology
  • Spatial Biology
Technical Service

Next Articles

There are no further posts.

Thank you for your submission.

Our team has received your request and will get back to you shortly with tailored workflows and relevant case studies for your ADC efficacy and toxicity evaluation needs.
If you do not receive our confirmation email, kindly check your spam or junk folder.

Thank you for your insterest

You can now download the file.

Connect with Us